Skip to content
Amkay Products logo

Amkay Products

544169 BSE
Price unavailable

Amkay Products (AMKAY) share price was ₹53.00 at the 27 Oct 2026 close; market capitalisation ₹45.84 Cr; P/E (TTM) 25.24; sector Healthcare. The share price rose 20.7% over the year to 27 Oct 2026 (adjusted for splits and bonuses). In the Mar 2026 quarter, revenue fell 7.5% year on year to ₹19.02 Cr and net profit fell 77.5% year on year to ₹0.34 Cr (compared with Mar 2025). Promoters held 73.44% of Amkay Products in Sep 2026, unchanged from Jun 2026.

Close 27 Oct 2026 ₹53.00 +7.02 +15.27% 1Y

Key Fundamentals

SMEHealthcare Equipment & SuppliesHealthcare
Market Cap
₹45.84 Cr
P/E (TTM)
25.24
EBITDA
₹4.50 Cr
Return on Equity
8.76%
Debt to Equity
0.15
Book Value
₹30.47
EPS (TTM)
₹2.10
52W High
₹81.99
52W Low
₹43.00

Price-based figures as of 27 Oct 2026, 15:30 IST · TTM

Peer Comparison

Healthcare › Medical Equipment › Medical Equipment & Supplies

Poly Medicure
₹1,464.1047.0914,840 Cr4.780.24%10.18%13.33%2,115 Cr313 Cr
Fischer Medical Ventures
₹26.2969.181,721 Cr3.760.20%8.11%12.69%373 Cr24 Cr
Tarsons Products
₹308.15147.441,640 Cr2.580.66%2.26%4.82%468 Cr11 Cr
Q-Line Biotech
₹550.0026.071,283 Cr2.630.00%22.63%26.37%201 Cr34 Cr
Laxmi Dental
₹178.5031.82982 Cr4.040.00%10.83%11.51%289 Cr31 Cr
Hemant Surgical Industries
——832 Cr5.310.00%13.22%19.52%——
Amkay Products (this company)
—25.2446 Cr1.740.00%8.76%13.42%18 Cr1 Cr
Median 7 companies₹308.1539.461,283 Cr3.760.00%10.18%13.33%331 Cr28 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company. 1 company is not shown because they are not listed on an exchange we cover.

Tapetide Score

Data-driven rating, 0–100. How it works →

No Tapetide Score has been computed for this stock yet.

Key Insights

Weaknesses

3
  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of 0.68% over past five years.
  • Company has a low return on equity of 11.7% over last 3 years.

Technical Indicators

Oscillators

Bullish

Bearish
2
Neutral
2
Bullish
5

Overall

Bearish

Bearish
12
Neutral
2
Bullish
5

Moving Averages

Bearish

Bearish
10
Neutral
0
Bullish
0

Growth Rate

Revenue Growth
7.56% lower than 3Y

change over 1 year

Net Income Growth
-30.3% lower than 3Y

change over 1 year

Cash Flow Change
481%

change over 1 year

EBITDA Margin Change
-22.89%

change over 1 year Operating margin 4.57% · Mar 2026

Quarterly Results

Particulars Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Sales
14.37
16.69
17.84
20.55
23.01
19.02
Expenses
12.58
15.15
15.45
18.81
20.04
18.15
Operating Profit
1.79
1.54
2.39
1.74
2.97
0.87
OPM %
12.46%
9.23%
13.4%
8.47%
12.91%
4.57%
Other Income
0.48
0.76
0.73
0.59
0.39
0.28
Interest
0.24
0.28
0.18
0.14
0.25
0.18
Depreciation
0.26
0.3
0.34
0.49
0.43
0.46
PBT
1.77
1.72
2.6
1.7
2.68
0.51
Tax %
26.55%
23.26%
30%
10.59%
26.87%
33.33%
Net Profit
1.3
1.33
1.83
1.51
1.97
0.34
EPS (₹)
2.04
2.09
2.11
1.74
2.28
0.39
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales
26.41
40.63
36.47
27.86
31.07
38.39
42.03
Expenses
24.82
36.14
33.78
24.93
27.74
34.26
38.18
Operating Profit
1.59
4.49
2.69
2.93
3.33
4.13
3.85
OPM %
6.02%
11.05%
7.38%
10.52%
10.72%
10.76%
9.16%
Other Income
0.04
0.1
0.29
0.46
1.25
1.32
0.67
Interest
0.47
0.24
0.41
0.47
0.52
0.32
0.43
Depreciation
0.52
0.51
0.54
0.69
0.56
0.83
0.88
PBT
0.64
3.84
2.03
2.23
3.5
4.3
3.21
Tax %
25%
25%
28.08%
30.49%
24.86%
22.33%
27.73%
Net Profit
0.48
2.88
1.47
1.55
2.63
3.34
2.31
EPS (₹)
8
48
24.5
25.83
4.13
3.86
2.67
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
0.28
0.28
0.28
0.28
6.36
8.66
8.66
Reserves
2.42
5.67
5.93
7.1
3.64
15.41
17.72
Borrowings
1.62
0.42
4.33
4.7
5.47
2.64
3.92
Other Liabilities
2.55
7.69
5.26
2.9
2.47
3.18
3.01
Total Liabilities
6.87
14.06
15.8
14.98
17.94
29.89
33.31
Fixed Assets
0
0
3.91
2.4
2.58
4.14
4.27
CWIP
0
0
0
0
0
0.12
0
Investments
0
0.4
2.79
3.62
2.57
6.85
6.5
Other Assets
6.87
13.66
9.1
8.96
12.79
18.78
22.54
Total Assets
6.87
14.06
15.8
14.98
17.94
29.89
33.31
Figures in ₹ Crores

Cash Flow

Particulars Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
0
0
-0.25
0.01
-0.66
-0.31
1.18
Investing
0
0
-3.07
-0.34
0.48
-5.84
-0.4
Financing
0
0
2.59
0.31
0.24
7.58
0.86
Net Cash Flow
0
0
-0.72
-0.01
0.06
1.43
1.64
Free Cash Flow
0
0
-2.4
-0.01
-1.82
-3.04
-0.08
CFO/EBITDA
0
0
10
32
7
17
54
Figures in ₹ Crores

Ratios

Particulars Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
31.23
40.43
36.33
48.47
46.87
57.14
42.81
Inventory Days
4.54
4.18
28.03
46.61
92.57
113
125
Days Payable
41.76
82.57
64.42
44.46
33.99
36.44
28.98
Cash Conversion Cycle
-5.98
-37.96
-0.06
50.62
105
134
139
Working Capital Days
10.78
-8.62
21.12
54.11
56.15
104
96.4
ROCE %
—
76.33%
28.86%
20.87%
22.36%
16.88%
12.03%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Amkay Products insights

55 extracted metrics + investor summaries across FY20–FY26.

Shareholding Pattern

Promot.73.44%Others2.52%Public24.04%As ofSep 2026

Documents

Frequently Asked Questions about Amkay Products

What does Amkay Products Ltd do?
Incorporated in 2007, Amkay Products Ltd manufactures personalized healthcare products[1]
Where is Amkay Products Ltd (AMKAY) listed?
Amkay Products Ltd trades under code 544169 on the BSE.
Which sector does Amkay Products Ltd belong to?
Amkay Products Ltd is classified under the Healthcare sector, in the Medical Equipment industry.
What is the market capitalisation of Amkay Products Ltd?
Amkay Products Ltd has a market capitalisation of ₹45.84 Cr as of 27 Oct 2026, which places it in the Small Cap band.
What is the PE ratio of Amkay Products Ltd?
Amkay Products Ltd trades at a PE ratio of 25.24 as of 27 Oct 2026, on earnings per share of ₹2.1, against a book value of ₹30.47 per share.
What is the 52-week high and low of Amkay Products Ltd?
Over the last 52 weeks Amkay Products Ltd has traded between ₹43 and ₹81.99 as of 27 Oct 2026.
What is the Return on Equity (ROE) of Amkay Products Ltd?
Amkay Products Ltd reported a return on equity of 8.76%. Its debt-to-equity ratio is 0.15.

Company Information

Incorporated in 2007, Amkay Products Ltd manufactures personalized healthcare products[1]

Website amkayproducts.com
Listed 2024-05-08
Face Value ₹ 10
Shares Outstanding 86,48,649

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/544169.md for Amkay Products Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Healthcare Equipment stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month